Logo for Mirum Pharmaceuticals, Inc.

Zone Director, West

Role overview

Qualifications

  • Bachelor’s degree required; advanced degree preferred (MBA, etc.)
  • 7+ years pharmaceutical/biotech experience, plus minimum of 5 years of leadership experience
  • Successful experience leading leaders (second-line leadership) highly desired
  • Significant rare disease and/or specialty experience

Responsibilities

  • Own and deliver Zone business performance across the liver portfolio
  • Lead, coach, and develop first-line leaders to maximize team effectiveness
  • Ensure consistent and high-quality execution of brand strategy in the field
  • Partner with Marketing, Market Access, Medical Affairs, Patient Services and Operations

About the company

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

Pharmaceutical Manufacturing

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three available medications: LIVMARLI® (maralixibat) oral solution, Cholbam® (cholic acid) capsules, and Chenodal® (chenodiol) tablets. LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients five years of age and older. Mirum has submitted for approval in Europe for the treatment of PFIC in patients two months of age and older. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms or liver disease. CHENODAL has received medical necessity recognition by the FDA to treat patients with cerebrotendinous xanthomatosis (CTX). Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases. Volixibat, an IBAT inhibitor, is being evaluated in two potentially registrational studies including the Phase 2b VISTAS study for primary sclerosing cholangitis and Phase 2b VANTAGE study for primary biliary cholangitis. Lastly, CHENODAL has been evaluated in a Phase 3 clinical study, RESTORE, to treat patients with CTX, with positive topline results reported in 2023.

Company details

Company typeScaleup
IndustryPharmaceutical Manufacturing
Company size201 - 500

Your match analysis

See how your profile stacks up against this role.

We compared the job requirements to your profile to show where you're strong and where you fall short.

Job description

MISSION

Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.

POSITION SUMMARY 

The Zone Director is a second-line field leader responsible for driving commercial performance, building 4 high-performing Region Business Director (RBD) teams, and ensuring execution excellence across the liver portfolio. This role translates national strategy into regional impact, with a strong emphasis on rare disease expertise, patient-centricity, and cross-functional leadership.

Assigned Area: WA, OR, CA, NV, AZ, UT, ID MT, WY, CO, NM, TX, KS, SD, ND, OK. LA, AR, MO, IA, MN, WI, IL, KY, MS, AL

JOB FUNCTIONS/RESPONSIBILITIES

Enterprise Leadership

  • Own and deliver Zone business performance across the liver portfolio with a strategic, big-picture mindset
  • Drive change and innovation
  • Develop and execute zone-specific business plans aligned to national strategy
  • Analyze market trends, competitive dynamics, and performance data to inform actions

Team Leadership & Development

  • Lead, coach, and develop first-line leaders to maximize team effectiveness
  • Build a strong leadership pipeline and succession plans
  • Foster a culture of accountability, engagement, and continuous improvement

Execution Excellence

  • Ensure consistent and high-quality execution of brand strategy in the field
  • Monitor KPIs and drive disciplined performance management
  • Identify and scale best practices across regions

Cross-Functional Collaboration 

  • Partner with Marketing, Market Access, Medical Affairs, Patient Services and Operations
  • Ensure alignment on strategy and coordinated execution
  • Provide field insights to inform brand planning and lifecycle strategy

Market & Customer Engagement

  • Maintain strategic relationships with key opinion leaders (KOLs) and top accounts
  • Understand regional nuances in referral patterns and treatment pathways
  • Support teams in navigating complex access and reimbursement environments 

Compliance & Ethical Leadership

  • Ensure all activities comply with regulatory, legal, and company policies
  • Model integrity and patient-first decision making
  • Reinforce a culture of compliance across the organization 

QUALIFICATIONS

Education/Experience:

  • Bachelor’s degree required; advanced degree preferred (MBA, etc.)
  • 7+ years pharmaceutical/biotech experience, plus minimum of 5 years of leadership experience
  • Successful experience leading leaders (second-line leadership) highly desired
    • Significant rare disease and/or specialty experience
    • Experience in rare liver disease a plus
    • Proven success in product launches, ideally with first-in-class therapies and in competitive markets
    • Demonstrated ability to build, lead, train and develop high-performing teams
    • Proven success in sales leadership roles with the ability to inspire, influence and align teams
  • Experience navigating complex rare disease patient journeys, including diagnosis, referral pathways, and difficult access to therapies
  • Strong leadership presence with the ability to inspire, influence, and align teams
  • Strong understanding of market access, payer dynamics, and patient services
  • Demonstrated ability to lead in a matrixed organization
  • High integrity, ethical standards, and commitment to compliance
  • Thrives in a fast-paced, dynamic, and collaborative environment
  • Able to travel frequently, up to 70% overnight travel and has a valid drivers’ license

#LI-REMOTE

Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.

Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.

 

Apply once. Then go straight to the hiring manager.

After you apply, unlock the direct contact details of the people who actually make the call. A quick follow-up makes you 5x more likely to land an interview.

MR

Marcus Rivera

Chief Revenue Officer

m.rivera@company.com
linkedin.com/in/marcusrivera
Unlocked after you apply
·

Cinematographer Related jobs

Other jobs at Mirum Pharmaceuticals, Inc.

Premium

Reach out to the hiring manager directly.

Gain access to the contact details of the hiring managers who actually decide, and reach out to network with them directly. That, plus more when you upgrade:

  • Full match report with fit score and gaps
  • Career diagnostics on how recruiters read you
  • Curated company matches and warm intros
  • 48h early access to new roles

Cancel anytime.